Richard Cunningham
Chief Executive Officer at TYME TECHNOLOGIES, INC.
Richard Cunningham active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Director/Board Member | 23/11/2020 | - |
| Chief Executive Officer | 23/11/2020 | - | |
| ANEBULO PHARMACEUTICALS, INC. | Director/Board Member | 04/10/2023 | - |
| Chief Executive Officer | 04/10/2023 | - | |
Icagen-T, Inc.
 Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| President | - | - |
Career history of Richard Cunningham
Former positions of Richard Cunningham
| Companies | Position | Start | End |
|---|---|---|---|
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Director/Board Member | 31/03/2020 | 31/10/2020 |
| Chief Executive Officer | 31/10/2014 | 31/10/2020 | |
| President | 31/10/2014 | 31/10/2020 |
Statistics
International
| United States | 5 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 4 |
| President | 2 |
Sectoral
| Health Technology | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Health Technology |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Stock Market
- Insiders
- Richard Cunningham
- Experience
